Tag archive for ‘Allergan Inc’
News Brief On Friday, November 13th, 2015

Valeant, Ackman must face U.S. insider trading lawsuit

  A U.S. judge said Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) and activist hedge fund manager William Ackman must face a lawsuit accusing them of insider trading in Allergan Inc before More...

Teva secures $34 billion financing for Allergan acquisition

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has entered into commitment letters relating to its pending acquisition of Allergan’s generic pharmaceuticals business with Bank of America More...

Niva Goldberg On Sunday, July 26th, 2015

Three Way Takeover Battle: Teva set to buy Allergan’s generics unit – WSJ

Teva likely mean the end of Teva’s pursuit of another Teva Pharmaceutical Industries Ltd. likely mean the end of pursuit of Mylan acquisition. The Israeli world’s biggest generic pharmaceutical maker More...

Vered Weiss On Monday, March 9th, 2015

What Plans Does Bill Ackman Have for Valeant with his $3.3 Billion Stake?

Pershing Square’s Bill Ackman didn’t manage to make Valeant into a successful hunter, so one wonders, with his $3.3 billion stake, as reported by Reuters, will he make Valeant, like he did Allergan, More...

Vered Weiss On Thursday, February 12th, 2015

Allergan CEO Says Fighting Off Activist Bill Ackman Was Full Time Job

One thing Allergan CEO David Pyott enjoyed doing was running his company. When activist investor Bill Ackman of Pershing Square decided to have Valeant Pharmaceuticals try to swallow up the Botox maker in a More...

Reuters On Friday, November 21st, 2014

Goldman Sachs is No. 1 as M&A adviser

– Global M&A deals cross $3 trillion for first time since 2007 –   Mergers and acquisition deals announced so far this year have topped $3 trillion, the highest since 2007, helped by More...

Reuters On Tuesday, November 18th, 2014

Ackman supports Allergan’s $66 billion sale to Actavis

– Activist investor William “Bill” Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and will withdraw his request for an Allergan special shareholder More...

Yoel Bermant On Monday, July 29th, 2013

Pharmaceutical industry giant Perrigo wins the $8.6 billion battle for Elan of Ireland

– There’s a lot happening in the pharmaceutical industry these days and one of the biggest deals so far this year will see US based Perrigo swallow up the Eire based Elan. Perrigo are the only non-Israeli More...

Wordpress site Developed by Fixing WordPress Problems